KENILWORTH, N.J. & SAN MATEO, Calif.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Afferent Pharmaceuticals announced today that the two companies have ...

Back in February, Afferent Pharmaceuticals pronounced itself satisfied with the outcome for a mid-stage study of its lead drug, AF-219, being developed for a range of conditions including pain, ...

Novartis said that current CEO and chairman Daniel Vasella will hand over the chief-executive role to Joe Jimenez, who currently heads the company’s pharmaceuticals division, effective February 1.